Analysis of Breast Cancer Mortality in the US-1975 to 2019.

ABSTRACT:

Importance

Breast cancer mortality in the US declined between 1975 and 2019. The association of changes in metastatic breast cancer treatment with improved breast cancer mortality is unclear.

Objective

To simulate the relative associations of breast cancer screening, treatment of stage I to III breast cancer, and treatment of metastatic breast cancer with improved breast cancer mortality.

Design, setting, and participants

Using aggregated observational and clinical trial data on the dissemination and effects of screening and treatment, 4 Cancer Intervention and Surveillance Modeling Network (CISNET) models simulated US breast cancer mortality rates. Death due to breast cancer, overall and by estrogen receptor and ERBB2 (formerly HER2) status, among women aged 30 to 79

SUBMITTER: Caswell-Jin JL 

PROVIDER: S-EPMC10792466 | biostudies-literature | 2024 Jan

REPOSITORIES: biostudies-literature